Fundamentals data is not available for this company.
Year Ending | Revenue ($m) | Pre-tax ($m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-25 | n/a | (307.02) | (241.86)¢ | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-26 | 7.17 | (385.06) | (312.71)¢ | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-27 | 25.62 | (445.07) | (335.04)¢ | n/a | n/a | n/a | n/a | 0.0% |
Copyright © 2025 FactSet Research Systems Inc. All rights reserved.
Viking Therapeutics soars 120% following positiv... | 18-Sep-2018 | ShareCast |
Currency | US Dollars |
Share Price | $ 23.09 |
Change Today | $ -0.60 |
% Change | -2.53 % |
52 Week High | $78.03 |
52 Week Low | $21.28 |
Volume | 5,690 |
Shares Issued | 72.03m |
Market Cap | $1,663.12m |
RiskGrade | 326 |
Strong Buy | 7 |
Buy | 9 |
Neutral | 1 |
Sell | 0 |
Strong Sell | 0 |
Total | 17 |
You are here: research